Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.03 CNY
−1.11 B CNY
90.44 M CNY
223.88 M
About DIZAL (JIANGSU) PHARMACEUTICAL
Sector
CEO
Xiao Lin Zhang
Website
Headquarters
Shanghai
Founded
2017
ISIN
CNE1000055W8
FIGI
BBG00ZLKRN31
Dizal (Jiangsu) Pharmaceutical Co., Ltd. engages in the discovery, development, and commercialization of innovative medicines. It researches, develops translational science, new-drug molecular design, and screening technology for the treatment of cancer, immunological diseases, and chronic kidney diseases. The company was founded by Xiao Lin Zhang on October 27, 2017 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688192 is 41.47 CNY — it has decreased by −1.08% in the past 24 hours. Watch DIZAL (JIANGSU) PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange DIZAL (JIANGSU) PHARMACEUTICAL stocks are traded under the ticker 688192.
688192 stock has fallen by −0.54% compared to the previous week, the month change is a −11.58% fall, over the last year DIZAL (JIANGSU) PHARMACEUTICAL has showed a −10.28% decrease.
We've gathered analysts' opinions on DIZAL (JIANGSU) PHARMACEUTICAL future price: according to them, 688192 price has a max estimate of 61.82 CNY and a min estimate of 54.00 CNY. Watch 688192 chart and read a more detailed DIZAL (JIANGSU) PHARMACEUTICAL stock forecast: see what analysts think of DIZAL (JIANGSU) PHARMACEUTICAL and suggest that you do with its stocks.
688192 reached its all-time high on Apr 17, 2023 with the price of 56.12 CNY, and its all-time low was 19.02 CNY and was reached on Apr 27, 2022. View more price dynamics on 688192 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688192 stock is 2.80% volatile and has beta coefficient of 1.38. Track DIZAL (JIANGSU) PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is DIZAL (JIANGSU) PHARMACEUTICAL there?
Today DIZAL (JIANGSU) PHARMACEUTICAL has the market capitalization of 17.59 B, it has decreased by −1.52% over the last week.
Yes, you can track DIZAL (JIANGSU) PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
DIZAL (JIANGSU) PHARMACEUTICAL is going to release the next earnings report on Feb 24, 2025. Keep track of upcoming events with our Earnings Calendar.
688192 net income for the last quarter is −213.71 M CNY, while the quarter before that showed −120.52 M CNY of net income which accounts for −77.33% change. Track more DIZAL (JIANGSU) PHARMACEUTICAL financial stats to get the full picture.
No, 688192 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 581.00 employees. See our rating of the largest employees — is DIZAL (JIANGSU) PHARMACEUTICAL on this list?
Like other stocks, 688192 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIZAL (JIANGSU) PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIZAL (JIANGSU) PHARMACEUTICAL technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIZAL (JIANGSU) PHARMACEUTICAL stock shows the neutral signal. See more of DIZAL (JIANGSU) PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.